FindTrial
Sign In

A clinical study comparing Hemolasertherapy and I-PRF for the treatment of Black triangle

Comparative evaluation of the Efficacy of Injectable Platelet rich fibrin and Hemolaser Therapy in Interdental papilla Reconstruction A clinical study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072144
Enrollment
50
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K056- Periodontal disease, unspecified

Interventions

Intervention1: Hemolasertherapy (HLT): Hemolasertherapy (HLT) is a nonsurgical treatment modality based on Photo Biomodulation of mesenchymal cells within the blood. Frequency is Once (At baseline) Du

Sponsors

Deepikashree K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects exhibiting a healthy periodontium aside from deficient papilla as determined by score 2 of Cardaropoli Papilla Presence Index Presence of good oral hygiene maintenance Systemically healthy patients Non smoker

Exclusion criteria

Exclusion criteria: Immunocompromised patients Pregnant and lactating women Patients who have undergone periodontal surgery in same area within last 6 months Patients under any medication known to affect the periodontium Patients with bruxism Patients exhibiting parafunctional habits and traumatic occlusion

Design outcomes

Primary

MeasureTime frame
Papillary RegenerationTimepoint: 1 month 3 months and 6 months—

Secondary

MeasureTime frame
The secondary outcomes will be an improvement in Plaque Index Gingival Index Gingival thicknessTimepoint: 12 TO 18 MONTHS—

Countries

India

Contacts

Public ContactDeepikashree K

Adhiparasakthi Dental College and Hospital

drmagesh76@gmail.com7060027511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026